Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00961961 · ClinicalTrials.gov registry record · Phase 4
Prevention of Relapse & Recurrence of Bipolar Depression
A Phase 4 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 177
- Enrollment target
NCT00961961: Completed Phase 4 study, sponsored by University of Pennsylvania.
NCT00961961 is a Phase 4 study that has completed, run by University of Pennsylvania. The registered enrollment target is 177 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00961961, a Phase 4 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 177 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the long-term use of combined antidepressant plus mood stabilizer therapy is superior to mood stabilizer therapy alone in preventing the relapse and recurrence of bipolar depression.
Interventions
- DRUG Lithium / Fluoxetine
- DRUG Lithium / Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2009-07-01 |
| Est. Completion | 2016-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00961961
The ClinicalTrials.gov registry entry for NCT00961961 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lithium / Fluoxetine is the first listed.
NCT00961961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00961961 about?
NCT00961961 is a clinical study titled "Prevention of Relapse & Recurrence of Bipolar Depression". The purpose of this study is to determine whether the long-term use of combined antidepressant plus mood stabilizer therapy is superior to mood stabilizer therapy alone in preventing the relapse and recurrence of bipolar depression.
What is the current status of trial NCT00961961?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 177 participants. The study started on 2009-07-01. Estimated completion is 2016-09-01.
What interventions are being tested in trial NCT00961961?
The interventions under investigation include: Lithium / Fluoxetine (DRUG), Lithium / Placebo (DRUG).
Who is sponsoring clinical trial NCT00961961?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.